IAEA partners, national representatives and independent experts met in Vienna last month to discuss how the quality, efficiency and effectiveness of the evidence gathered and guidance provided by IAEA-led cancer control reviews (imPACT Reviews) could be strengthened to support Member States improve their cancer control services.
As the IAEA will soon be conducting its hundredth imPACT Review (scheduled to take place in 2019), it’s timely to evaluate the overall methodology for the Reviews, and ensure imPACT’s continued importance in the future.
The meeting brought together important imPACT Review partners, the World Health Organization (WHO) and the International Agency for Cancer Research (IARC), together with Divisions from across the IAEA that are working on cancer control. Representatives from Member States common to both the IAEA and WHO, and independent experts, also attended.
Beyond being a major health issue for individuals and governments, cancer has also become a development challenge for countries around the world. New data released by IARC in September indicates that the number of people globally developing cancer this year will exceed 18 million, with 9.6 million dying. By 2030, annual figures are projected to rise to 24 million cases, with 13 million deaths each year.